Effectiveness of oral corticosteroids (prednisolone) in sensorineural hearing loss post COVID-19

Background Numerous infections can result in neurological symptoms, including anosmia, facial paralysis, and abrupt sensorineural hearing loss (SSNHL). During the earlier SARS pandemic, coronaviruses were linked to a loss of smell and taste due to brain damage. Purpose To clinically detect corticost...

Full description

Saved in:
Bibliographic Details
Published in:The Egyptian journal of otolaryngology 2022-12, Vol.38 (1), p.162-9, Article 162
Main Author: Essawy, Wessam Mostafa
Format: Article
Language:English
Subjects:
Age
Antigens
Audiometry
Brain damage
Coronaviruses
Corticosteroid therapy (methylprednisolone)
Corticosteroids
COVID-19
COVID-19 infection
Disease transmission
Epidemics
Health aspects
Hearing loss
Hypertension
Infection
Infections
Medicine
Medicine & Public Health
Methylprednisolone
Olfaction disorders
Original
Original Article
Pandemics
Paralysis
Patients
Prednisolone
Prognosis
Severe acute respiratory syndrome coronavirus 2
Steroids
Sudden sensorineural hearing loss (SSNHL)
Surgery
Tinnitus
Vertigo
Viral infections
Virus diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Numerous infections can result in neurological symptoms, including anosmia, facial paralysis, and abrupt sensorineural hearing loss (SSNHL). During the earlier SARS pandemic, coronaviruses were linked to a loss of smell and taste due to brain damage. Purpose To clinically detect corticosteroid treatment effectiveness in SSNHL post-COVID-19 infection and to detect the factors that affect the prognosis for these patients for better diagnosis and earlier management. Subjects and method Subjects included 20 subjects diagnosed by PCR as COVID-19 virus positive, complaining of sudden onset hearing loss post viral infection in different durations. All subjects had basic audiological evaluation done pre-treatment and repeated after 1 week, 2 weeks, and 1 month after treatment with methylprednisolone 21-acetate tablets. Results Onset of hearing loss post-COVID infection ranged from 1 to 3 months. As regards the improvement recognized with treatment course, thirteen patients (65%) of all twenty patients showed complete improvement at 1 month after starting treatment, and seven patients (35%) showed no improvement even after 1 month. Conclusion SSNHL has been widely recognized in the context of COVID-19 to date. Early corticosteroid therapy could help in the recovery of hearing, especially if the beginning of therapy was early in the first 2 weeks.
ISSN:1012-5574
2090-8539
DOI:10.1186/s43163-022-00347-2